London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Kimberley Billingsley
)
- Job title
- Institution
- National Institutes of Health, USA
- Biography
Kimberley Billingsley leads the Applied Neurogenomics group within the National Institutes of Health Center for Alzheimer’s and Related Dementias (CARD). Her research focuses on understanding the impact of complex genetic variations, such as structural variants, on neurodegenerative diseases, including Alzheimer's and Parkinson's. Kimberley develops scalable workflows for long-read sequencing and integrates multi-omics data to identify translational targets, advancing equitable research across diverse populations.
- Recent publications
Billingsley, K.J. et al. Long-read sequencing of hundreds of diverse brains provides insight into the impact of structural variation on gene expression and DNA methylation. bioRxiv. 12.16.628723 (2024). DOI: 10.1101/2024.12.16.628723
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.